RICHARD TWOY: Open Payments
NPI 1174641526 · SAN JOSE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$696 in 6 payments from 5 companies in 2025. Trend: 2023 $1,922 · 2024 $1,562 · 2025 $696
Food & beverage: $696
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $222 |
| GENZYME CORPORATION | 1 | $150 |
| Fresenius Kabi USA, LLC | 1 | $127 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $72 |
Products named: CAPLYTA, DUPIXENT, Smoflipid, XIFAXAN.
Industry payments across CA — which companies pay providers there.
